Sustained Ventricular Tachycardia in Apparently Normal Hearts: Medical Therapy Should be the First Step in Management.

Ali Kazemi Saeid, George J Klein, Peter Leong-Sit

Journal: Cardiac electrophysiology clinics 2017;8(3):631-9

PMID: 27521096

Full Text on Elsevier Science View on PubMed

Abstract

Sustained monomorphic ventricular tachycardia or repetitive premature ventricular complexes can be seen in patients with structurally normal hearts. Among these types of patients, the prognosis is predominantly benign and the treatment mostly focused on elimination of symptoms rather than improving survival or reduction of mortality. This article focuses on the pharmacologic options for management and compares them with invasive options. Based on the current literature, we demonstrate that medical therapies should be used as first-line management and favored over invasive therapies. Understanding the arrhythmia mechanism is critical in choosing the appropriate medication among the wide variety of antiarrhythmic drugs available.

Address: Western University, London, Ontario, Canada.; Western University, London, Ontario, Canada. Electronic address: [email protected].

DOI: 10.1016/j.ccep.2016.04.012

Link outs

Free resources

Other Literature Sources:

https://scite.ai/reports/27521096

Subscription / membership required

Full Text Sources:

MeSH Terms: Adult, Aged, Calcium Channel Blockers, Humans, Middle Aged, Tachycardia, Ventricular, Ventricular Premature Complexes